DK158784A - Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa - Google Patents

Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa Download PDF

Info

Publication number
DK158784A
DK158784A DK158784A DK158784A DK158784A DK 158784 A DK158784 A DK 158784A DK 158784 A DK158784 A DK 158784A DK 158784 A DK158784 A DK 158784A DK 158784 A DK158784 A DK 158784A
Authority
DK
Denmark
Prior art keywords
pseudomonas aeruginosa
mucoid
exopolysaccharid
vaccine against
against pseudomonas
Prior art date
Application number
DK158784A
Other languages
English (en)
Other versions
DK158784D0 (da
Inventor
Gerald B Pier
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of DK158784D0 publication Critical patent/DK158784D0/da
Publication of DK158784A publication Critical patent/DK158784A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • C12R2001/385—Pseudomonas aeruginosa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/874—Pseudomonas
    • Y10S435/875—Pseudomonas aeruginosa

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK158784A 1983-03-23 1984-03-19 Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa DK158784A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/477,958 US4578458A (en) 1983-03-23 1983-03-23 Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa

Publications (2)

Publication Number Publication Date
DK158784D0 DK158784D0 (da) 1984-03-19
DK158784A true DK158784A (da) 1984-09-24

Family

ID=23898005

Family Applications (1)

Application Number Title Priority Date Filing Date
DK158784A DK158784A (da) 1983-03-23 1984-03-19 Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa

Country Status (7)

Country Link
US (1) US4578458A (da)
EP (1) EP0120532B1 (da)
AT (1) ATE52695T1 (da)
AU (1) AU571495B2 (da)
CA (1) CA1226543A (da)
DE (1) DE3482241D1 (da)
DK (1) DK158784A (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
AT384032B (de) * 1985-01-14 1987-09-25 Immuno Ag Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
US5114712A (en) * 1985-11-14 1992-05-19 Mitsui Toatsu Chemicals, Inc. Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5169840A (en) * 1991-03-27 1992-12-08 Nobipols Forskningsstiftelse Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
US5233024A (en) * 1991-04-09 1993-08-03 The Brigham & Women's Hospital Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
DE4204012A1 (de) * 1992-02-12 1993-08-19 Ulrich Prof Dr Zimmermann Mitogenfreie substanz, deren herstellung und verwendung
WO1994008617A1 (en) * 1992-10-16 1994-04-28 Brigham And Women's Hospital, Inc. O-derivatized alginic acid antigens
US5633234A (en) * 1993-01-22 1997-05-27 The Johns Hopkins University Lysosomal targeting of immunogens
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
RU2159127C1 (ru) * 1999-03-03 2000-11-20 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Вакцина против псевдомоноза пушных зверей
RU2147318C1 (ru) * 1999-08-12 2000-04-10 Научно-исследовательский институт пушного звероводства и кролиководства им.В.А.Афанасьева Штамм бактерий pseudomonas aeruginosa 5241, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169191C2 (ru) * 1999-08-12 2001-06-20 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 5291, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169765C2 (ru) * 1999-08-12 2001-06-27 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 5002, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169766C2 (ru) * 1999-08-12 2001-06-27 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa ло1, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169188C2 (ru) * 1999-08-12 2001-06-20 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 4492, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169195C2 (ru) * 1999-08-12 2001-06-20 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 5271, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169193C2 (ru) * 1999-08-12 2001-06-20 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 5142, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169192C2 (ru) * 1999-08-12 2001-06-20 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa лоз, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169189C2 (ru) * 1999-08-12 2001-06-20 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 4762, используемый для изготовления вакцины против псевдомоноза пушных зверей
RU2169190C2 (ru) * 1999-08-12 2001-06-20 Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий pseudomonas aeruginosa 5292, используемый для изготовления вакцины против псевдомоноза пушных зверей
KR100397793B1 (ko) 2000-07-28 2003-09-13 삼성전자주식회사 느릅나무로부터 분리된 신규의 미생물 및 그를 이용한항암 면역활성의 세포밖 당화합물의 제조방법
US6962813B2 (en) * 2001-05-21 2005-11-08 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US7119172B2 (en) * 2001-05-21 2006-10-10 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
AU2003290867A1 (en) * 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
AU2003291872A1 (en) * 2002-12-04 2004-06-23 Inrs (Institut National De Recherche Scientifique) An exopolysaccharides delivery system for active molecules
AU2005236068C1 (en) 2004-04-21 2012-08-30 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
US20060062779A1 (en) * 2004-09-21 2006-03-23 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
CA2646539A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
KR20110031393A (ko) 2008-07-21 2011-03-25 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
RU2388488C1 (ru) * 2008-10-13 2010-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования Кубанский государственный аграрный университет Вакцина против псевдомоноза нутрий
RU2388487C1 (ru) * 2008-10-13 2010-05-10 Федеральное государственное образовательное учреждение высшего профессионального образования Кубанский государственный аграрный университет Способ изготовления вакцины против псевдомоноза нутрий
WO2020163512A1 (en) 2019-02-05 2020-08-13 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2290219A1 (fr) * 1974-11-05 1976-06-04 Pasteur Institut Principe actif de vaccin antipyocyanique
US4285936A (en) * 1979-12-10 1981-08-25 The United States Of America As Represented By The Secretary Of The Army Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa

Also Published As

Publication number Publication date
DK158784D0 (da) 1984-03-19
US4578458A (en) 1986-03-25
EP0120532B1 (en) 1990-05-16
EP0120532A3 (en) 1985-12-18
DE3482241D1 (de) 1990-06-21
AU2548184A (en) 1984-09-27
EP0120532A2 (en) 1984-10-03
AU571495B2 (en) 1988-04-21
ATE52695T1 (de) 1990-06-15
CA1226543A (en) 1987-09-08

Similar Documents

Publication Publication Date Title
DK158784A (da) Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa
SE8404707D0 (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
DK39991D0 (da) Oral immunisering
AU543201B2 (en) Vaccinal complex containing a specific antigen and vaccine containing it
ES2125901T3 (es) Empleo de lipasas para la obtencion de medicamentos.
ATE165515T1 (de) Immuntoleranzinduzierendes agens
FI885464A7 (fi) Asyylioksiasyylihydrolaasi ja sen käyttö
ES8501719A1 (es) Un metodo para inhibir el crecimiento de bacterias en aguas de refrigeracion industrial.
AU2152988A (en) Intranasal vaccination of horses with inactivated microorganisms or antigenic material
AP8700068A0 (en) Vaccine and method of preparation.
DE3576247D1 (de) Piezoelektrische vorrichtung des aufgestapelten typs und anwendungsverfahren.
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
LU90378I2 (fr) Tetravac
KR830005871A (ko) 광견병 백신의 제조방법
DK0427462T3 (da) Fremgangsmåde
FI910359L (fi) Menetelmä gram-negatiivisten bakteerien määrittämiseksi ja erottamiseksi
IL105498A0 (en) Pharmaceutical composition containing ribonucleotide polymerase
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
IT8723085A0 (it) Epitopo immunodominante protettivo contenuto nella subunita' s1 della tossina della pertosse.
EP0189841A3 (en) Enzymatic detection of bacterial capsular polysaccharide antigens
NL194960B (nl) Werkwijze voor het bereiden van mutantstammen van Bordetella bronchiseptica en daarop gebaseerd levend verzwakt vaccin.
NO931655L (no) Syntetiske lipid a glykokonjugatantigener for anvendelse i vaksiner
JPS5781416A (en) Cilia of pseudomonas aeruginosa and method of using cilia as vaccine of pseudomonas aeruginosa infections
Horak Phytotoxins produced by pathovars of Pseudomonas syringae
Szegli et al. Gram-negative bacterial infection and acute knee joint arthritis.

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1997 00029, 970716

CTFG Supplementary protection certificate (spc) issued

Free format text: CA 1997 00029, 970716, EXPIRES: 20001108

PUP Patent expired
AHS Application shelved for other reasons than non-payment